Xybion Digital Inc. to Present at Gravitas’ 5th Annual Growth Conference
VANCOUVER, BC and PRINCETON, NJ / ACCESSWIRE / February 24, 2022 / Xybion Digital Inc. (TSXV: XYBN) (“Xybion” or the “Company”), a global, low-code SaaS company that enables digital transformation in highly regulated industries like Life Sciences, announced today that it will be presenting at the Gravitas’ 5th Annual Growth Conference taking place at the Fairmont Pacific Rim Hotel and also virtually on Thursday, March 3rd, 2022, in Vancouver, British Columbia.
Dr. Pradip Banerjee, Chairman and CEO of Xybion Digital is scheduled to present on Thursday, March 3rd, 2022, at 10:40am PST. Dr. Banerjee will be fielding investor questions, hosting individual investors meetings and presentations during the one-day virtual and in-person conference hosted by Gravitas Securities Inc. “Our invitation to the Gravitas’ 5th Annual Growth Conference is a great opportunity for investors to discover Xybion Digital’s unique value offered to the global life sciences industry,” said Dr. Pradip Banerjee.
Gravitas’ 5th Annual Growth Conference will feature leaders at the forefront of their industries in today’s growth sectors and will be attended by institutional and retail investors from Canada, the United States, and abroad. For additional details about the conference and Gravitas Securities Inc., please visit: www.gravitassecurities.com
Event: Gravitas’ 5th Annual Growth Conference
Format: Presentations, Q&A, and Panel Discussion
Date: Thursday, March 3rd, 2022
Time: 8:00 AM PST – 5:30 PM PST
Venue: Held virtually, and in-person at the Fairmont Pacific Rim Hotel: 1038 Canada Place, Vancouver, BC, V6C 0B9
About Xybion Digital Inc.
Xybion is a global SaaS company that helps enterprise life sciences organizations accelerate new drug development into approved medicines that may save lives and keep employees safe. We digitize drug research and development, laboratory testing, regulatory approvals, and pharmaceutical manufacturing on a single, unified cloud platform that is cost-effective, ready to deploy, and easy to use. Xybion has over 160 clients in 29 countries using its low-code software to accelerate timelines, improve compliance, expand capacity, minimize operating risks, and reduce expenses while keeping employees safe.
Learn more about Xybion at https://www.xybion.com/
For further information: For more information regarding Xybion Digital Inc., please contact Pradip Banerjee, Chief Executive Officer, PBanerjee@xybion.com, 609-512-5790 x122
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Certain statements (“forward-looking statements“) in this news release may contain forward-looking information concerning relating to the release of financial results, plans related to the Company’s business and other matters that may occur in the future, made as of the date of this news release. In making the forward-looking statements included in this news release, the Company has applied several material assumptions, including with respect to the timing of such release. Although management considers these assumptions to be reasonable based on information available to it, they may prove to be incorrect.
Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements as a number of important factors could cause the actual outcomes to differ materially from the expectations expressed in them. Such factors include, among others, the risks described in disclosure documents filed by the Company on SEDAR. There can be no assurance that forward-looking statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as otherwise required by applicable securities legislation.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act“), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.